2023-2029 Global Enteral Nutrition Drug Industry Research & Trends Analysis Report
Enteral nutrition drugs, also known as enteral nutrition preparations, are a generic term for a variety of products used in clinical enteral nutrition support, whose nutritional composition mainly includes a balance of various proteins, amino acids, sugars, fats, vitamins, minerals, dietary fibre, etc. The raw materials are mainly derived from terrestrial animal and plant extracts.
This report aims to provide a comprehensive study of the global market for Enteral Nutrition Drug. Report Highlights:
(1) Global Enteral Nutrition Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Enteral Nutrition Drug market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Enteral Nutrition Drug market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Enteral Nutrition Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Enteral Nutrition Drug segment by type and by application and regional segment by type and by application.
(6) Enteral Nutrition Drug industry supply chain, upstream, midstream and downstream analysis.
According to YH Research, the global market for Enteral Nutrition Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Enteral Nutrition Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Enteral Nutrition Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Adults segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospitals has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Enteral Nutrition Drug include Hospira Inc, Fresenius Kabi, Danone, Knowmedical, Nestlé, B. Braun Melsungen AG, Abbott, Otsuka Pharmaceutical India Private Limited and NUTRICHEM DIÄT + PHARMA GMBH, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Adults
Children
Market segment by application, can be divided into
Hospitals
Clinics
Pharmaceutical Companies
Others
Market segment by players, this report covers
Hospira Inc
Fresenius Kabi
Danone
Knowmedical
Nestlé
B. Braun Melsungen AG
Abbott
Otsuka Pharmaceutical India Private Limited
NUTRICHEM DIÄT + PHARMA GMBH
Delta Drugs
Baxter
Allergan
Actavis Inc.
Grifols, S.A.
Vifor Pharma
1 Market Overview
1.1 Product Overview and Scope of Enteral Nutrition Drug
1.2 Global Enteral Nutrition Drug Market Size and Forecast
1.3 China Enteral Nutrition Drug Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Enteral Nutrition Drug Share in Global Market, 2018-2029
1.4.2 Enteral Nutrition Drug Market Size: China VS Global, 2018-2029
1.5 Enteral Nutrition Drug Market Dynamics
1.5.1 Enteral Nutrition Drug Market Drivers
1.5.2 Enteral Nutrition Drug Market Restraints
1.5.3 Enteral Nutrition Drug Industry Trends
1.5.4 Enteral Nutrition Drug Industry Policy
2 Global Competitive Situation by Company
2.1 Global Enteral Nutrition Drug Revenue by Company (2018-2023)
2.2 Global Enteral Nutrition Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Enteral Nutrition Drug Concentration Ratio
2.4 Global Enteral Nutrition Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Enteral Nutrition Drug Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Enteral Nutrition Drug Revenue by Company (2018-2023)
3.2 China Enteral Nutrition Drug Enteral Nutrition Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Enteral Nutrition Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Enteral Nutrition Drug Industry Chain
4.2 Enteral Nutrition Drug Upstream Analysis
4.3 Enteral Nutrition Drug Midstream Analysis
4.4 Enteral Nutrition Drug Downstream Analysis
5 Sights by Type
5.1 Enteral Nutrition Drug Classification
5.1.1 Adults
5.1.2 Children
5.2 By Type, Global Enteral Nutrition Drug Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Enteral Nutrition Drug Revenue, 2018-2029
6 Sights by Application
6.1 Enteral Nutrition Drug Segment by Application
6.1.1 Hospitals
6.1.2 Clinics
6.1.3 Pharmaceutical Companies
6.1.4 Others
6.2 By Application, Global Enteral Nutrition Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Enteral Nutrition Drug Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Enteral Nutrition Drug Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Enteral Nutrition Drug Market Size, 2018-2029
7.3 North America
7.3.1 North America Enteral Nutrition Drug Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Enteral Nutrition Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Enteral Nutrition Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Enteral Nutrition Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Enteral Nutrition Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Enteral Nutrition Drug Market Size Market Share
7.6 South America
7.6.1 South America Enteral Nutrition Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Enteral Nutrition Drug Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Enteral Nutrition Drug Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Enteral Nutrition Drug Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Enteral Nutrition Drug Market Size, 2018-2029
8.3.2 By Company, U.S. Enteral Nutrition Drug Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Enteral Nutrition Drug Market Size, 2018-2029
8.4.2 By Company, Europe Enteral Nutrition Drug Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Enteral Nutrition Drug Market Size, 2018-2029
8.5.2 By Company, China Enteral Nutrition Drug Revenue Market Share, 2018-2023
8.5.3 By Type, China Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Enteral Nutrition Drug Market Size, 2018-2029
8.6.2 By Company, Japan Enteral Nutrition Drug Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Enteral Nutrition Drug Market Size, 2018-2029
8.7.2 By Company, South Korea Enteral Nutrition Drug Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Enteral Nutrition Drug Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Enteral Nutrition Drug Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Enteral Nutrition Drug Market Size, 2018-2029
8.9.2 By Company, India Enteral Nutrition Drug Revenue Market Share, 2018-2023
8.9.3 By Type, India Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Enteral Nutrition Drug Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Enteral Nutrition Drug Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Hospira Inc
9.1.1 Hospira Inc Company Information, Head Office, Market Area and Industry Position
9.1.2 Hospira Inc Company Profile and Main Business
9.1.3 Hospira Inc Enteral Nutrition Drug Models, Specifications and Application
9.1.4 Hospira Inc Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.1.5 Hospira Inc Recent Developments
9.2 Fresenius Kabi
9.2.1 Fresenius Kabi Company Information, Head Office, Market Area and Industry Position
9.2.2 Fresenius Kabi Company Profile and Main Business
9.2.3 Fresenius Kabi Enteral Nutrition Drug Models, Specifications and Application
9.2.4 Fresenius Kabi Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.2.5 Fresenius Kabi Recent Developments
9.3 Danone
9.3.1 Danone Company Information, Head Office, Market Area and Industry Position
9.3.2 Danone Company Profile and Main Business
9.3.3 Danone Enteral Nutrition Drug Models, Specifications and Application
9.3.4 Danone Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.3.5 Danone Recent Developments
9.4 Knowmedical
9.4.1 Knowmedical Company Information, Head Office, Market Area and Industry Position
9.4.2 Knowmedical Company Profile and Main Business
9.4.3 Knowmedical Enteral Nutrition Drug Models, Specifications and Application
9.4.4 Knowmedical Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.4.5 Knowmedical Recent Developments
9.5 Nestlé
9.5.1 Nestlé Company Information, Head Office, Market Area and Industry Position
9.5.2 Nestlé Company Profile and Main Business
9.5.3 Nestlé Enteral Nutrition Drug Models, Specifications and Application
9.5.4 Nestlé Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.5.5 Nestlé Recent Developments
9.6 B. Braun Melsungen AG
9.6.1 B. Braun Melsungen AG Company Information, Head Office, Market Area and Industry Position
9.6.2 B. Braun Melsungen AG Company Profile and Main Business
9.6.3 B. Braun Melsungen AG Enteral Nutrition Drug Models, Specifications and Application
9.6.4 B. Braun Melsungen AG Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.6.5 B. Braun Melsungen AG Recent Developments
9.7 Abbott
9.7.1 Abbott Company Information, Head Office, Market Area and Industry Position
9.7.2 Abbott Company Profile and Main Business
9.7.3 Abbott Enteral Nutrition Drug Models, Specifications and Application
9.7.4 Abbott Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.7.5 Abbott Recent Developments
9.8 Otsuka Pharmaceutical India Private Limited
9.8.1 Otsuka Pharmaceutical India Private Limited Company Information, Head Office, Market Area and Industry Position
9.8.2 Otsuka Pharmaceutical India Private Limited Company Profile and Main Business
9.8.3 Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Models, Specifications and Application
9.8.4 Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.8.5 Otsuka Pharmaceutical India Private Limited Recent Developments
9.9 NUTRICHEM DIÄT + PHARMA GMBH
9.9.1 NUTRICHEM DIÄT + PHARMA GMBH Company Information, Head Office, Market Area and Industry Position
9.9.2 NUTRICHEM DIÄT + PHARMA GMBH Company Profile and Main Business
9.9.3 NUTRICHEM DIÄT + PHARMA GMBH Enteral Nutrition Drug Models, Specifications and Application
9.9.4 NUTRICHEM DIÄT + PHARMA GMBH Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.9.5 NUTRICHEM DIÄT + PHARMA GMBH Recent Developments
9.10 Delta Drugs
9.10.1 Delta Drugs Company Information, Head Office, Market Area and Industry Position
9.10.2 Delta Drugs Company Profile and Main Business
9.10.3 Delta Drugs Enteral Nutrition Drug Models, Specifications and Application
9.10.4 Delta Drugs Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.10.5 Delta Drugs Recent Developments
9.11 Baxter
9.11.1 Baxter Company Information, Head Office, Market Area and Industry Position
9.11.2 Baxter Company Profile and Main Business
9.11.3 Baxter Enteral Nutrition Drug Models, Specifications and Application
9.11.4 Baxter Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.11.5 Baxter Recent Developments
9.12 Allergan
9.12.1 Allergan Company Information, Head Office, Market Area and Industry Position
9.12.2 Allergan Company Profile and Main Business
9.12.3 Allergan Enteral Nutrition Drug Models, Specifications and Application
9.12.4 Allergan Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.12.5 Allergan Recent Developments
9.13 Actavis Inc.
9.13.1 Actavis Inc. Company Information, Head Office, Market Area and Industry Position
9.13.2 Actavis Inc. Company Profile and Main Business
9.13.3 Actavis Inc. Enteral Nutrition Drug Models, Specifications and Application
9.13.4 Actavis Inc. Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.13.5 Actavis Inc. Recent Developments
9.14 Grifols, S.A.
9.14.1 Grifols, S.A. Company Information, Head Office, Market Area and Industry Position
9.14.2 Grifols, S.A. Company Profile and Main Business
9.14.3 Grifols, S.A. Enteral Nutrition Drug Models, Specifications and Application
9.14.4 Grifols, S.A. Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.14.5 Grifols, S.A. Recent Developments
9.15 Vifor Pharma
9.15.1 Vifor Pharma Company Information, Head Office, Market Area and Industry Position
9.15.2 Vifor Pharma Company Profile and Main Business
9.15.3 Vifor Pharma Enteral Nutrition Drug Models, Specifications and Application
9.15.4 Vifor Pharma Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
9.15.5 Vifor Pharma Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. Enteral Nutrition Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Enteral Nutrition Drug Market Restraints
Table 3. Enteral Nutrition Drug Market Trends
Table 4. Enteral Nutrition Drug Industry Policy
Table 5. Global Enteral Nutrition Drug Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Enteral Nutrition Drug Revenue Market Share by Company (2018-2023)
Table 7. Global Enteral Nutrition Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Enteral Nutrition Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Enteral Nutrition Drug Manufacturers Product Type
Table 10. China Enteral Nutrition Drug Revenue by Company (2018-2023) & (US$ million)
Table 11. China Enteral Nutrition Drug Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Enteral Nutrition Drug Upstream (Raw Materials)
Table 13. Global Enteral Nutrition Drug Typical Customers
Table 14. Enteral Nutrition Drug Typical Distributors
Table 15. By Type, Global Enteral Nutrition Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Enteral Nutrition Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Enteral Nutrition Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Enteral Nutrition Drug Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Enteral Nutrition Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Enteral Nutrition Drug Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Enteral Nutrition Drug Revenue Market Share, 2018-2029
Table 22. Hospira Inc Company Information, Head Office, Market Area and Industry Position
Table 23. Hospira Inc Company Profile and Main Business
Table 24. Hospira Inc Enteral Nutrition Drug Models, Specifications and Application
Table 25. Hospira Inc Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 26. Hospira Inc Recent Developments
Table 27. Fresenius Kabi Company Information, Head Office, Market Area and Industry Position
Table 28. Fresenius Kabi Company Profile and Main Business
Table 29. Fresenius Kabi Enteral Nutrition Drug Models, Specifications and Application
Table 30. Fresenius Kabi Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 31. Fresenius Kabi Recent Developments
Table 32. Danone Company Information, Head Office, Market Area and Industry Position
Table 33. Danone Company Profile and Main Business
Table 34. Danone Enteral Nutrition Drug Models, Specifications and Application
Table 35. Danone Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 36. Danone Recent Developments
Table 37. Knowmedical Company Information, Head Office, Market Area and Industry Position
Table 38. Knowmedical Company Profile and Main Business
Table 39. Knowmedical Enteral Nutrition Drug Models, Specifications and Application
Table 40. Knowmedical Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 41. Knowmedical Recent Developments
Table 42. Nestlé Company Information, Head Office, Market Area and Industry Position
Table 43. Nestlé Company Profile and Main Business
Table 44. Nestlé Enteral Nutrition Drug Models, Specifications and Application
Table 45. Nestlé Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 46. Nestlé Recent Developments
Table 47. B. Braun Melsungen AG Company Information, Head Office, Market Area and Industry Position
Table 48. B. Braun Melsungen AG Company Profile and Main Business
Table 49. B. Braun Melsungen AG Enteral Nutrition Drug Models, Specifications and Application
Table 50. B. Braun Melsungen AG Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 51. B. Braun Melsungen AG Recent Developments
Table 52. Abbott Company Information, Head Office, Market Area and Industry Position
Table 53. Abbott Company Profile and Main Business
Table 54. Abbott Enteral Nutrition Drug Models, Specifications and Application
Table 55. Abbott Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 56. Abbott Recent Developments
Table 57. Otsuka Pharmaceutical India Private Limited Company Information, Head Office, Market Area and Industry Position
Table 58. Otsuka Pharmaceutical India Private Limited Company Profile and Main Business
Table 59. Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Models, Specifications and Application
Table 60. Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 61. Otsuka Pharmaceutical India Private Limited Recent Developments
Table 62. NUTRICHEM DIÄT + PHARMA GMBH Company Information, Head Office, Market Area and Industry Position
Table 63. NUTRICHEM DIÄT + PHARMA GMBH Company Profile and Main Business
Table 64. NUTRICHEM DIÄT + PHARMA GMBH Enteral Nutrition Drug Models, Specifications and Application
Table 65. NUTRICHEM DIÄT + PHARMA GMBH Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 66. NUTRICHEM DIÄT + PHARMA GMBH Recent Developments
Table 67. Delta Drugs Company Information, Head Office, Market Area and Industry Position
Table 68. Delta Drugs Company Profile and Main Business
Table 69. Delta Drugs Enteral Nutrition Drug Models, Specifications and Application
Table 70. Delta Drugs Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 71. Delta Drugs Recent Developments
Table 72. Baxter Company Information, Head Office, Market Area and Industry Position
Table 73. Baxter Company Profile and Main Business
Table 74. Baxter Enteral Nutrition Drug Models, Specifications and Application
Table 75. Baxter Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 76. Baxter Recent Developments
Table 77. Allergan Company Information, Head Office, Market Area and Industry Position
Table 78. Allergan Company Profile and Main Business
Table 79. Allergan Enteral Nutrition Drug Models, Specifications and Application
Table 80. Allergan Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 81. Allergan Recent Developments
Table 82. Actavis Inc. Company Information, Head Office, Market Area and Industry Position
Table 83. Actavis Inc. Company Profile and Main Business
Table 84. Actavis Inc. Enteral Nutrition Drug Models, Specifications and Application
Table 85. Actavis Inc. Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 86. Actavis Inc. Recent Developments
Table 87. Grifols, S.A. Company Information, Head Office, Market Area and Industry Position
Table 88. Grifols, S.A. Company Profile and Main Business
Table 89. Grifols, S.A. Enteral Nutrition Drug Models, Specifications and Application
Table 90. Grifols, S.A. Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 91. Grifols, S.A. Recent Developments
Table 92. Vifor Pharma Company Information, Head Office, Market Area and Industry Position
Table 93. Vifor Pharma Company Profile and Main Business
Table 94. Vifor Pharma Enteral Nutrition Drug Models, Specifications and Application
Table 95. Vifor Pharma Enteral Nutrition Drug Revenue and Gross Margin, 2018-2023
Table 96. Vifor Pharma Recent Developments
List of Figure
Figure 1. Enteral Nutrition Drug Picture
Figure 2. Global Enteral Nutrition Drug Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Enteral Nutrition Drug Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Enteral Nutrition Drug Market Share of Global
Figure 5. Global Enteral Nutrition Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Enteral Nutrition Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Enteral Nutrition Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Enteral Nutrition Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Enteral Nutrition Drug Industry Chain
Figure 10. Adults
Figure 11. Children
Figure 12. By Type, Global Enteral Nutrition Drug Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Enteral Nutrition Drug Revenue Market Share, 2018-2029
Figure 14. Hospitals
Figure 15. Clinics
Figure 16. Pharmaceutical Companies
Figure 17. Others
Figure 18. By Application, Global Enteral Nutrition Drug Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global Enteral Nutrition Drug Revenue Market Share, 2018-2029
Figure 20. By Region, Global Enteral Nutrition Drug Revenue Market Share, 2018-2029
Figure 21. North America Enteral Nutrition Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Enteral Nutrition Drug Revenue Market Share, 2018-2023
Figure 23. Europe Enteral Nutrition Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Enteral Nutrition Drug Revenue Market Share, 2018-2023
Figure 25. Asia Pacific Enteral Nutrition Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Enteral Nutrition Drug Revenue Market Share, 2018-2023
Figure 27. South America Enteral Nutrition Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Enteral Nutrition Drug Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa Enteral Nutrition Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Enteral Nutrition Drug Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. Enteral Nutrition Drug Market Share, 2018-2023
Figure 32. By Type, U.S. Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 34. Europe Enteral Nutrition Drug Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe Enteral Nutrition Drug Market Share, 2018-2023
Figure 36. By Type, Europe Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 38. China Enteral Nutrition Drug Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China Enteral Nutrition Drug Market Share, 2018-2023
Figure 40. By Type, China Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 42. Japan Enteral Nutrition Drug Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan Enteral Nutrition Drug Market Share, 2018-2023
Figure 44. By Type, Japan Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 46. South Korea Enteral Nutrition Drug Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea Enteral Nutrition Drug Market Share, 2018-2023
Figure 48. By Type, South Korea Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia Enteral Nutrition Drug Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia Enteral Nutrition Drug Market Share, 2018-2023
Figure 52. By Type, Southeast Asia Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 54. India Enteral Nutrition Drug Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India Enteral Nutrition Drug Market Share, 2018-2023
Figure 56. By Type, India Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia Enteral Nutrition Drug Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia Enteral Nutrition Drug Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia Enteral Nutrition Drug Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets